Clinical Data, Inc. To Present at BIO CEO & Investor Conference

NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a corporate overview at the BIO CEO & Investor Conference on Tuesday, February 10, 2009 at The Waldorf-Astoria in New York City. Clinical Data’s presentation will take place at 12:00 p.m. ET in the Park room. A live audio and archived webcast of the Company presentation can be accessed through the Company’s website at www.clda.com.

Mr. Fromkin will also be participating in a panel presentation at the conference entitled: The Cure for Market Anxiety: M&A, on Tuesday, February 10^th from 3:15-4:20 p.m. in the East Foyer room.

About Clinical Data, Inc.

Clinical Data is a global biotechnology company unlocking the potential of molecular discovery, From Targeted Science to Better Healthcare^®. The Company’s PGxHealth^® division is utilizing its proprietary portfolio of biomarkers to develop and commercialize a broad range of targeted therapeutics as well as pharmacogenetic tests that help predict drug safety and efficacy, thereby reducing health care costs. Its Cogenics^® division provides genomics services to both research and regulated environments. Through these divisions, Clinical Data is leveraging advances in molecular discovery to provide tangible benefits for patients, doctors, scientists and health plans worldwide. To learn more, please visit the Company's website at www.clda.com.